Organization
InterCure Ltd.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
InterCure Ltd.
... mainly due to changes in fair value of marketable securities held in InterCure, a former subsidiary. Loss from continuing operations for the three months ended ...
... mainly due to changes in fair value of marketable securities held in InterCure, a former subsidiary. Loss from continuing operations for the three months ended ...
... largest shareholder, increased his stake in the Company through his investment in InterCure, an XTL subsidiary, and recent purchases of XTL stock in the market. ...
... financial markets. The recently announced transaction regarding the sale of 51% of InterCure, which is a non-core asset, to Green Forest Global, will allow the ...
... with $694,000 for the same period last year. Excluding expenses associated with InterCure, Ltd., the Company's medical device subsidiary, these costs would have been $369,000 ...
... to $700,000 for the same period last year. Excluding expenses associated with InterCure, Ltd., the Company's medical device subsidiary, these costs would have been $547,000 ...
... million for the year ended December 31, 2012. Excluding expenses associated with InterCure, Ltd., the Company's medical device subsidiary, these costs would have been $1.3 ...
Subscribe now for full coverage on InterCure Ltd.
Start My Free Trial